In this week's news, Covidien completes its acquisition of CV Ingenuity, and AtriCure announces three executive promotions.
Covidien (Dublin, Ireland) completed its acquisition of CV Ingenuity (Fremont, CA), which is developing a drug-coated balloon platform. The company joins Covidien’s vascular product line. (Press Release)
AtriCure, a maker of cardiac ablation systems, has made several executive promotions. Douglas J. Seith has been bumped up to senior vice president of sales and marketing, Michael Rogge is the company’s new vice president of marketing, and M. Andrew Wade has been promoted to vice president and chief financial officer. (Press Release)
Vicki Bebeau, formerly the senior clinical director for St. Jude Medical’s cardiovascular and international divisions, has joined Velomedix (Menlo Park, CA) as vice president of clinical affairs. Velomedix is a venture-backed medical device company developing products in the area of therapeutic hypothermia. (Market Watch)
Orthopedic manufacturer AxioMed Spine Corp. (Garfield Heights, OH) secured $3.6 million in funding from current and new investors in a new financing round. The company’s Freedom Lumbar and Cervical Discs are on the market in the EU and are awaiting FDA approval in the United States. (Business Wire)
—Jamie Hartford is MD+DI's managing editor.